Patient no. | Age (year) | Form | Pattern | CD3 | CCR7 | CXCR3 | CCR5 |
---|
 |  |  |  |  | Lining | Sublining | Aggregates | Lining | Sublining | Aggregates | Lining | Sublining | Aggregates |
---|
1 | 14 | Oligo per. | Diffuse | +++ | + | +++ | NP | +++ | +++ | NP | +++ | ++ | NP |
2 | 19 | Poly RF- | Diffuse | + | - | ++ | NP | + | +++ | NP | + | - | NP |
3 | 10 | Oligo per. | T-B | ++ | - | + | ++ | + | ++ | ++ | ++ | + | - |
4 | 12 | Oligo ext. | T-B | +++ | ++ | +++ | +++ | ++ | +++ | +++ | ++ | + | ++ |
5 | 7 | Poly RF- | T-B | ++ | - | - | + | ++ | +++ | +++ | +++ | + | + |
6 | 15 | Poly RF- | GC | +++ | - | + | ++ | +++ | +++ | +++ | +++ | + | - |
- Oligo per., persistent oligoarticular; oligo ext., extended oligoarticular; Poly RF-, polyarticular rheumatoid factor-negative; NP, not present; T-B, aggregates of T and B cells; GC, T and B cell aggregates with germinal centre (GC)-like reaction. Scoring: -, absence of positive cells in high-power field; +, 1–10 positive cells per high-power field; ++, 10–20 positive cells per high-power field; +++, more than 20 positive cells per high-power field (see also the Methods section). Lining, lining layer and superficial subintima; sublining, perivascular infiltrates in sublining layer; aggregates, T and B cell aggregates with or without GC-like reaction. All evaluations were performed in areas characterised by a clear lymphocyte (anti-CD3 and anti-CD4 positive cells) infiltration (see also the Methods section and Fig. 3).